Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
about
The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.Advances in small molecule therapy for treating metastatic thyroid cancer.Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.Therapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy.Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report.
P2860
Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Outcomes and Prognostic Factor ...... erentiated Thyroid Carcinomas.
@ast
Outcomes and Prognostic Factor ...... erentiated Thyroid Carcinomas.
@en
type
label
Outcomes and Prognostic Factor ...... erentiated Thyroid Carcinomas.
@ast
Outcomes and Prognostic Factor ...... erentiated Thyroid Carcinomas.
@en
prefLabel
Outcomes and Prognostic Factor ...... erentiated Thyroid Carcinomas.
@ast
Outcomes and Prognostic Factor ...... erentiated Thyroid Carcinomas.
@en
P2093
P2860
P1433
P1476
Outcomes and Prognostic Factor ...... erentiated Thyroid Carcinomas.
@en
P2093
Camille Buffet
Charlotte Lepoutre-Lussey
Fabrice Ménégaux
Frédérique Tissier
Jean-Marc Simon
Jean-Philippe Spano
Johanna Wassermann
Laurence Leenhardt
Marie-Odile Bernier
Monique Leban
P2860
P356
10.1634/THEONCOLOGIST.2015-0107
P577
2015-12-16T00:00:00Z